By adding the variate of PRL, our model provides an alternative method to easily identifying those with a high risk for NASH, thus may make liver biopsy unnecessary in a considerable proportion of patients. The gene discussed is PRL; the disease is metabolic dysfunction-associated steatohepatitis.